Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Surgery For Long Bone Fracture

PHASE4CompletedINTERVENTIONAL
Enrollment

82

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Femoral Fractures
Interventions
DRUG

Tranexamic Acid plus standard of care

Tranexamic acid given slowly intravenously (15 mg/kg body weight) 15 minutes before surgery followed by a second dose at three hour interval from first dose and third dose at three hour interval from the second + Standard of care (Standard of care includes the routine surgical and anesthetic techniques being utilized to control blood loss)

PROCEDURE

Standard of care

Standard of care includes the routine surgical and anesthetic techniques being utilized to control blood loss

Trial Locations (1)

641009

Pfizer Investigational Site, Coimbatore

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY